FDA-approved melanocortin receptor agonist (Vyleesi) for hypoactive sexual desire disorder. Used off-label in both sexes. Onset: 45–90 minutes.
Pre-filled with standard PT-141 values. Adjust as needed.
Standard: 1–2mg subcutaneously 45–90 min before sexual activity. Maximum once every 72 hours. Duration: up to 12 hours. Start with 1mg to assess tolerance.
Blood markers to track
Note: FDA-approved as Vyleesi. Common effects: flushing, nausea, headache. Monitor BP. Avoid with cardiovascular disease.
Log Blood pressure (PT-141 may temporarily elevate) and Testosterone across draws and let StackAI analyze your response. Free to start.
Track my PT-141 labs free →